Literature DB >> 18702916

A 49-year-old Hispanic male with intraepithelial neoplasia and focal atypia.

Mark Soloway1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18702916     DOI： 10.1007/s11934-008-0059-3

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN： 1527-2737            Impact factor:   3.092


× No keyword cloud information.
  24 in total

1.  Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies.

Authors:  C S Stewart; B C Leibovich; A L Weaver; M M Lieber
Journal:  J Urol       Date:  2001-07       Impact factor: 7.450

2.  Macronutrients, fatty acids, cholesterol and prostate cancer risk.

Authors:  E Bidoli; R Talamini; C Bosetti; E Negri; D Maruzzi; M Montella; S Franceschi; C La Vecchia
Journal:  Ann Oncol       Date:  2005-01       Impact factor: 32.976

3.  Effect of finasteride on the sensitivity of PSA for detecting prostate cancer.

Authors:  Ian M Thompson; Chen Chi; Donna Pauler Ankerst; Phyllis J Goodman; Catherine M Tangen; Scott M Lippman; M Scott Lucia; Howard L Parnes; Charles A Coltman
Journal:  J Natl Cancer Inst       Date:  2006-08-16       Impact factor: 13.506

4.  Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial.

Authors:  W J Catalona; A W Partin; K M Slawin; M K Brawer; R C Flanigan; A Patel; J P Richie; J B deKernion; P C Walsh; P T Scardino; P H Lange; E N Subong; R E Parson; G H Gasior; K G Loveland; P C Southwick
Journal:  JAMA       Date:  1998-05-20       Impact factor: 56.272

5.  Prediagnostic prostate-specific antigen velocity and probability of detecting high-grade prostate cancer.

Authors:  Stephanie C Krejcarek; Ming-Hui Chen; Andrew A Renshaw; Marian Loffredo; Brenda Sussman; Anthony V D'Amico
Journal:  Urology       Date:  2007-03       Impact factor: 2.649

6.  Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years old.

Authors:  Stacy Loeb; Kimberly A Roehl; Jo Ann V Antenor; William J Catalona; Brian K Suarez; Robert B Nadler
Journal:  Urology       Date:  2006-01-25       Impact factor: 2.649

7.  Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer.

Authors:  M C Benson; I S Whang; A Pantuck; K Ring; S A Kaplan; C A Olsson; W H Cooner
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

8.  Prostate cancer detection in the prostate specific antigen range of 2.0 to 3.9 ng/ml: value of percent free prostate specific antigen on tumor detection and tumor aggressiveness.

Authors:  Rene Raaijmakers; Bert G Blijenberg; Judith A Finlay; Harry G Rittenhouse; Mark F Wildhagen; Monique J Roobol; Fritz H Schröder
Journal:  J Urol       Date:  2004-06       Impact factor: 7.450

9.  Meat and meat mutagens and risk of prostate cancer in the Agricultural Health Study.

Authors:  Stella Koutros; Amanda J Cross; Dale P Sandler; Jane A Hoppin; Xiaomei Ma; Tongzhang Zheng; Michael C R Alavanja; Rashmi Sinha
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-01       Impact factor: 4.254

10.  Rate of change in serum prostate specific antigen levels as a method for prostate cancer detection.

Authors:  D S Smith; W J Catalona
Journal:  J Urol       Date:  1994-10       Impact factor: 7.450
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.